MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-09-2026
Neogen Corporation ROCE Ratio 2011-2026 | NEOG
Annual ROCE Ratio Neogen Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -51.22 | 1.87 | 1.2 | 6.61 | 8.83 | 9.31 | 10.36 | 12.12 | 13.19 | 13.33 | 14.48 | 13.55 | 14.92 | 14.57 | 17.75 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17.75 | -51.22 | 6.72 |
Quarterly ROCE Ratio Neogen Corporation
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | -0.25 | -0.49 | 0.19 | 0.26 | 0.99 | 2.68 | 4.53 | 8.78 | 9.93 | 10.97 | 10.94 | 9.52 | 9.48 | 9.64 | 9.59 | 9.8 | 10.52 | 10.91 | 11.28 | 11.67 | 12.06 | 12.49 | 13.03 | 13.59 | 14.13 | 14.55 | 14.71 | 15.06 | 15.08 | 14.91 | 15.27 | 15.09 | 14.9 | 14.97 | 15.11 | 15.15 | 16.03 | 15.52 | 15.84 | 15.37 | 15.72 | 16.63 | 16.55 | 17.53 | 17.44 | 17.04 | 17.24 | 16.75 | 16.93 | 4.47 | 4.04 | 4.64 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 17.53 | -0.49 | 11.51 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 1.62 | -2.12 % | $ 2.15 M |  USA |
 |
Agilent Technologies
A
|
25.0 | $ 115.05 | -0.49 % | $ 35 B | USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 24.54 | -1.76 % | $ 682 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M |  Israel |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Illumina
ILMN
|
-35.1 | $ 126.49 | -1.58 % | $ 20.1 B | USA |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 22.26 | 1.88 % | $ 1.19 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 83.21 | -1.08 % | $ 5.62 B | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 15.15 | -2.88 % | $ 458 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 165.64 | -3.26 % | $ 8.21 B | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 16.89 | -1.29 % | $ 378 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Guardant Health
GH
|
440.3 | $ 82.71 | -6.54 % | $ 10.4 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
6.33 | $ 27.06 | -1.74 % | $ 20 B |  Niderland |
 |
Precipio
PRPO
|
-8.25 | $ 32.25 | 5.05 % | $ 51.8 M | USA |
 |
Personalis
PSNL
|
-33.64 | $ 5.44 | -8.72 % | $ 322 M | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 1.93 | - | $ 8.54 M | USA |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 7.15 | -1.72 % | $ 298 M | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 413.83 | -1.79 % | $ 11.9 B | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | Niderland |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Biomerica
BMRA
|
-125.14 | $ 2.19 | 0.46 % | $ 5.03 M | USA |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 469.78 | 0.37 % | $ 177 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 100.97 | -2.18 % | $ 8.33 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 260.26 | -1.2 % | $ 21.7 B | USA |
 |
Trinity Biotech plc
TRIB
|
0.08 | $ 0.61 | -5.24 % | $ 61.9 M | Irlanda |
 |
Celcuity
CELC
|
-171.24 | $ 120.4 | -4.21 % | $ 5.63 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | $ 59.76 | -2.03 % | $ 3.57 B | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 8.86 | 2.85 % | $ 1.13 B | USA |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 4.87 | 0.72 % | $ 451 M | USA |
 |
Natera
NTRA
|
-76.66 | $ 201.83 | -1.25 % | $ 19.9 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 195.01 | -0.82 % | $ 21.6 B | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |
 |
OpGen
OPGN
|
4.4 | - | -16.95 % | $ 1.54 M | USA |